The world’s first self-stabilising walking exoskeleton, Atlante X, has entered a rehabilitation trial in Germany. The exoskeleton will be provided to patients with hemiparesis, an after-effect of stroke that causes muscle weakness on one side of the body. Atalante X’s efficacy will be compared with standard rehabilitation methods. The trial, named EarlyExo, will take place at two renowned neurorehabilitation clinics: the Vivantes Klinikum Spandau in Berlin and Schön Klinik Bad Aibling Harthausen near Munich. Both clinics will this month begin recruiting a total of 66 patients. “Recovery from a stroke and other acute neurological conditions is complex and can take…
This story continues at The Next WebRead More